Canagliflozin (Invokana, Invokamet) and Dapagliflozin (Farxiga, Xigduo XR): Drug Safety Communication - Strengthened Kidney Warnings
Revised warnings in the drug labels to include information about acute kidney injury and added recommendations to minimize this risk. (Source: FDA MedWatch Safety Alert)
Source: FDA MedWatch Safety Alert - June 14, 2016 Category: American Health Source Type: alerts
Canagliflozin (Invokana, Invokamet): Drug Safety Communication - Clinical Trial Results Find Increased Risk of Leg and Foot Amputations
FDA is currently investigating this new safety issue. Patients should not stop or change their diabetes medicines. (Source: FDA MedWatch Safety Alert)
Source: FDA MedWatch Safety Alert - May 18, 2016 Category: American Health Source Type: alerts
Invokana (canagliflozin)
Detailed View: Safety Labeling Changes Approved By FDA Center for Drug Evaluation and Research (CDER)
May 2016
WARNINGS AND PRECAUTIONS
Acute Kidney Injury and Impairment in Renal Function
INVOKANA causes intravascular volume... (Source: Drugs.com - Labeling Changes)
Source: Drugs.com - Labeling Changes - May 1, 2016 Category: Drugs & Pharmacology Source Type: alerts
Invokamet (canagliflozin and metformin hydrochloride) Tablets
Detailed View: Safety Labeling Changes Approved By FDA Center for Drug Evaluation and Research (CDER)
March 2016
CONTRAINDICATIONS
History of a serious hypersensitivity reaction to canagliflozin or metformin, such as anaphylaxis or... (Source: Drugs.com - Labeling Changes)
Source: Drugs.com - Labeling Changes - March 1, 2016 Category: Drugs & Pharmacology Source Type: alerts
Invokana (canagliflozin) Tablets
Detailed View: Safety Labeling Changes Approved By FDA Center for Drug Evaluation and Research (CDER)
March 2016
CONTRAINDICATIONS
History of a serious hypersensitivity reaction to Invokana, such as anaphylaxis or angioedema.
... (Source: Drugs.com - Labeling Changes)
Source: Drugs.com - Labeling Changes - March 1, 2016 Category: Drugs & Pharmacology Source Type: alerts
Farxiga (dapagliflozin) Tablets
Detailed View: Safety Labeling Changes Approved By FDA Center for Drug Evaluation and Research (CDER)
December 2015
Including
Farxiga (dapagliflozin) Tablets
Glyxambi (empagliflozin and linagliptin) Tablets
Invokana... (Source: Drugs.com - Labeling Changes)
Source: Drugs.com - Labeling Changes - December 1, 2015 Category: Drugs & Pharmacology Source Type: alerts
Glyxambi (empagliflozin and linagliptin) Tablets
Detailed View: Safety Labeling Changes Approved By FDA Center for Drug Evaluation and Research (CDER)
December 2015
Including
Farxiga (dapagliflozin) Tablets
Glyxambi (empagliflozin and linagliptin) Tablets
Invokana... (Source: Drugs.com - Labeling Changes)
Source: Drugs.com - Labeling Changes - December 1, 2015 Category: Drugs & Pharmacology Source Type: alerts
Jardiance (empagliflozin) Tablets
Detailed View: Safety Labeling Changes Approved By FDA Center for Drug Evaluation and Research (CDER)
December 2015
Including
Farxiga (dapagliflozin) Tablets
Glyxambi (empagliflozin and linagliptin) Tablets
Invokana... (Source: Drugs.com - Labeling Changes)
Source: Drugs.com - Labeling Changes - December 1, 2015 Category: Drugs & Pharmacology Source Type: alerts
Synjardy (empagliflozin and metformin hydrochloride) Tablets
Detailed View: Safety Labeling Changes Approved By FDA Center for Drug Evaluation and Research (CDER)
December 2015
Including
Farxiga (dapagliflozin) Tablets
Glyxambi (empagliflozin and linagliptin) Tablets
Invokana... (Source: Drugs.com - Labeling Changes)
Source: Drugs.com - Labeling Changes - December 1, 2015 Category: Drugs & Pharmacology Source Type: alerts
Xigduo XR (dapagliflozin and metformin HCl extended release) Tablets
Detailed View: Safety Labeling Changes Approved By FDA Center for Drug Evaluation and Research (CDER)
December 2015
Including
Farxiga (dapagliflozin) Tablets
Glyxambi (empagliflozin and linagliptin) Tablets
Invokana... (Source: Drugs.com - Labeling Changes)
Source: Drugs.com - Labeling Changes - December 1, 2015 Category: Drugs & Pharmacology Source Type: alerts
Invokamet (canagliflozin and metformin HCl) Tablets
Detailed View: Safety Labeling Changes Approved By FDA Center for Drug Evaluation and Research (CDER)
December 2015
Including
Farxiga (dapagliflozin) Tablets
Glyxambi (empagliflozin and linagliptin) Tablets
Invokana... (Source: Drugs.com - Labeling Changes)
Source: Drugs.com - Labeling Changes - December 1, 2015 Category: Drugs & Pharmacology Source Type: alerts
Invokana (canagliflozin) Tablets
Detailed View: Safety Labeling Changes Approved By FDA Center for Drug Evaluation and Research (CDER)
December 2015
Including
Farxiga (dapagliflozin) Tablets
Glyxambi (empagliflozin and linagliptin) Tablets
Invokana... (Source: Drugs.com - Labeling Changes)
Source: Drugs.com - Labeling Changes - December 1, 2015 Category: Drugs & Pharmacology Source Type: alerts
INVOKANA (Canagliflozin) Tablet, Film Coated [Janssen Pharmaceuticals, Inc.]
Updated Date: Apr 12, 2013 EST (Source: DailyMed Drug Label Updates for the last seven days (since May 20, 2007 EST))
Source: DailyMed Drug Label Updates for the last seven days (since May 20, 2007 EST) - April 12, 2013 Category: Drugs & Pharmacology Source Type: alerts
